España
India
Italia
대한민국
日本
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Research
Benzinga Pro
Log In
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Get Benzinga Pro
Data & APIs
Events
Marketfy
Premarket
Boost
Advertise
Contribute
España
India
Italia
대한민국
日本
Sign in
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Government
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Cryptocurrency
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Genprex
GNPX
NASDAQ
Watchlist
Get Report
Perks
Buy
Compare Brokers
$1.90
-0.01
-0.52%
At Close: -
$1.96
0.06
3.16%
After Hours: Jul 1, 8:21 AM EDT
15 minutes delayed
Get Report
Watch
Genprex (GNPX) Forecast
News
Earnings
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest news for Genprex (NASDAQ:GNPX) Stock
Genprex Stock (NASDAQ: GNPX)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Thursday, June 27, 2024
Genprex shares are trading higher after the c...
Benzinga Newsdesk
Genprex Issues Letter And Provides 2024 Updat...
Benzinga Newsdesk
Friday, May 31, 2024
12 Health Care Stocks Moving In Friday's Intraday Session
Benzinga Insights
Friday, May 17, 2024
HC Wainwright & Co. Reiterates Buy on Genprex...
Benzinga Newsdesk
Wednesday, May 15, 2024
HC Wainwright & Co. Reiterates Buy on Genprex...
Benzinga Newsdesk
Tuesday, May 14, 2024
Genprex Administers First Dose In Acclaim-3 C...
Benzinga Newsdesk
Monday, May 13, 2024
Genprex Appoints Jose A. Moreno Toscano As Ch...
Benzinga Newsdesk
Friday, April 26, 2024
12 Health Care Stocks Moving In Friday's Pre-Market Session
Benzinga Insights
Tuesday, April 09, 2024
Genprex Earlier Reported Preclinical Data For...
Benzinga Newsdesk
Thursday, April 04, 2024
HC Wainwright & Co. Reiterates Buy on Genprex...
Benzinga Newsdesk
Wednesday, April 03, 2024
Genprex Expands Clinical Trial Sites For Accl...
Benzinga Newsdesk
HC Wainwright & Co. Reiterates Buy on Genprex...
Benzinga Newsdesk
Tuesday, April 02, 2024
Genprex Publishes Preclinical Data With NPRL2...
Benzinga Newsdesk
Monday, March 25, 2024
HC Wainwright & Co. Initiates Coverage On Gen...
Benzinga Newsdesk
Tuesday, March 19, 2024
12 Health Care Stocks Moving In Tuesday's Intraday Session
Benzinga Insights
Genprex shares are trading lower after the co...
Benzinga Newsdesk
Genprex Announces $6.5M Registered Direct Off...
Benzinga Newsdesk
Tuesday, March 12, 2024
Genprex Receives Notice Of Patent Grant For K...
Benzinga Newsdesk
Wednesday, March 06, 2024
Why United Natural Foods Shares Are Trading Lower By 15%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Avi Kapoor
Genprex Collaborators To Present Preclinical ...
Benzinga Newsdesk
Wednesday, February 07, 2024
Genprex Expands Nonclinical Programs Through ...
Benzinga Newsdesk
Monday, February 05, 2024
Genprex Has Enrolled And Dosed The First Pati...
Benzinga Newsdesk
Friday, February 02, 2024
Trading Halt: Halt status updated at 8:55:00 ...
Benzinga Newsdesk
Trading Halt: Halted at 7:50:00 p.m. ET - Tra...
Benzinga Newsdesk
Wednesday, January 31, 2024
Dow Turns Lower; Federal Reserve Keeps Rates Unchanged
Avi Kapoor
Why AMD Shares Are Trading Lower? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Avi Kapoor
Genprex shares are trading lower after the co...
Benzinga Newsdesk
Crude Oil Down 2%; Alphabet Shares Fall After Q4 Results
Avi Kapoor
Genprex Announces 1-for-40 Reverse Stock Spli...
Benzinga Newsdesk
Thursday, January 11, 2024
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Benzinga Insights
Tuesday, January 09, 2024
12 Health Care Stocks Moving In Tuesday's Intraday Session
Benzinga Insights
Friday, January 05, 2024
Genprex Says Acclaim-1 Phase 2A And Acclaim-3...
Benzinga Newsdesk
Friday, December 15, 2023
12 Health Care Stocks Moving In Friday's After-Market Session
Benzinga Insights
Wednesday, December 13, 2023
Genprex May Offer And Sell, From Time To Time Shares Of Common Stock Having Offering Price Of Up To $25M
Charles Gross
Friday, November 17, 2023
12 Health Care Stocks Moving In Friday's Pre-Market Session
Benzinga Insights
Thursday, November 02, 2023
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Benzinga Insights
Wednesday, October 04, 2023
Genprex To Present Data On The Use Of REQORSA...
Benzinga Newsdesk
Friday, September 22, 2023
12 Health Care Stocks Moving In Friday's After-Market Session
Benzinga Insights
Thursday, September 21, 2023
Stocks That Hit 52-Week Lows On Thursday
Benzinga Insights
Genprex Inc. Receives Orphan Drug Designation For Immunogene Therapy For Treatment Of SCLC
Happy Mohamed
Wednesday, August 30, 2023
12 Health Care Stocks Moving In Wednesday's After-Market Session
Benzinga Insights
Thursday, August 10, 2023
Genprex Granted FDA Orphan Drug Designation F...
Benzinga Newsdesk
Wednesday, August 09, 2023
Genprex Gets FDA Orphan Drug Designation For Quaratusugene Ozeplasmid For Treatment Of Small Cell Lung Cancer
Happy Mohamed
Wednesday, July 19, 2023
Genprex shares are trading lower after the co...
Benzinga Newsdesk
Why Amarin Shares Are Trading Lower By 23%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Lisa Levin
12 Health Care Stocks Moving In Wednesday's Intraday Session
Benzinga Insights
Genprex Announces $7.5M Registered Direct Offering With An Instatutional Investor For The Sale And Issuance Of 7,425,744 Shares And Warrants At A Combined Price Of $1.01/Unit, Priced At-the-Market Under Nasdaq Rules
Happy Mohamed
Tuesday, July 18, 2023
Genprex – FDA Grants Fast Track Approval For Promising New Cancer Gene Therapy
Johnny Rice
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Benzinga Insights
Genprex Signs Exclusive License To Additional Diabetes Technology With The University Of Pittsburgh
Happy Mohamed
Show More
Create a Watchlist
FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.
Click to Get Started
People Also Watch